MERRIFIELD C ANN

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 55% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
MERRIFIELD C ANN's trades of Lyra Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
307.26
Quantity 54,980 +32.3%
Value US$4,958,076
Transaction date
Purchase
Price
439.58
Quantity 66,855 +32.0%
Value US$3,720,276
Transaction date
Purchase
Price
244.00
Quantity 35,147 +45.5%
Value US$3,279,856
Transaction date
Purchase
Price
8.97
Quantity 3,500 +inf%
Value US$31,395
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-06-13 2022-06-10
B Purchase
54,980 +32.3%
307.26
US$4,958,076 		54,980 +32.3% 307.26 US$4,958,076
2022-05-17 2022-05-16
B Purchase
66,855 +32.0%
439.58
US$3,720,276 		66,855 +32.0% 439.58 US$3,720,276
2022-05-17 2022-05-13
B Purchase
35,147 +45.5%
244.00
US$3,279,856 		35,147 +45.5% 244.00 US$3,279,856
2021-06-22 2021-06-17
B Purchase
3,500 +inf%
8.97
US$31,395 		3,500 +inf% 8.97 US$31,395
2020-03-12 2020-03-10
B Purchase
3,636
0.00
US$0 		3,636 0.00 US$0
2019-05-24 2019-05-23
B Purchase
8,000 +400.0%
12.64
US$101,120 		8,000 +400.0% 12.64 US$101,120
2015-08-14 2015-08-12
B Purchase
2,000 +inf%
12.36
US$24,718 		2,000 +inf% 12.36 US$24,718